@9FD900cxqj6NbAs @QuickToshi COVID-19のECMO導入後90日以内の経過で、こちらは全文読めます。 https://t.co/zlrG60p1SW
@A_F_Hegazy @WHaddaraMed @docpgb @critical367 @arntfield @kwadwo777 Is it fair to say it's "experimental"? The outcomes of COVID ARDS on ECMO don't seem that much different than non-COVID ARDS on ECMO based on publication data at least https://t.co/8MB…
@DrToddLee @WHaddaraMed @docpgb @critical367 @arntfield @kwadwo777 https://t.co/8MB6Bwvn72 67 (6%) remained hospitalised, 311 (30%) were discharged home or to an acute rehabilitation centre, 101 (10%) were discharged to a long-term acute care centre or…
@scottmartinMD The nation wide survival rate in patient with COVID and ECMO is just over 50%. I would take a 1 in 2 chance of survival given that most cannulations are done in younger patients. https://t.co/rK1TuGWUh6
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @jrdelbrio: Repaso de lo más destacable sobre #ECMO durante el último año. @FOAMecmo impecable e infatigable, como siempre. @ECMOHUVH @…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @iceman_ex: Great thread.
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @jrdelbrio: Repaso de lo más destacable sobre #ECMO durante el último año. @FOAMecmo impecable e infatigable, como siempre. @ECMOHUVH @…
4/@doctorbrijpatel:#ECMO en #COVID19:Cohorte multicéntrico internacional (1035 Pts) 6% hospitalizados 5 meses después de iniciado ECMO 30% egresados a casa 27% a centros de cuidados crónicos u otro hospital 💥Mortalidad 37.4% a 90 días #ATS2021 👉 http…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @jrdelbrio: Repaso de lo más destacable sobre #ECMO durante el último año. @FOAMecmo impecable e infatigable, como siempre. @ECMOHUVH @…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @iceman_ex: Great thread.
Great thread.
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/8Lfhc4JMhH replies https://t.co/0vOkFlWnYG + https://t.co/isKWpv8sve 2⃣ECMO in #COVID19 analysis of @ELSOOrg registry @TheLancet …
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
Kanın dışarıda oksijenlendirilmesi (EKMO) Ventilasyon yerine benden başkaları da düşünmüş tabii ki : )) "ECMO alan COVID-19 hastalarında ECMO'dan 90 gün sonra tahmini mortalite hem de son ölüm veya taburculuk eğilimi olanlarda mortalite% 40'tan azdı." …
#ECMO in #COVID19 respiratory failure? -> follow #ARDS management algorithm -> evidence increasing... lot left to learn! Brodie D @ctsnetorg @asaiojournal webinar; read 📃@RyanPBarbaro https://t.co/CTJJFRWKsf 📃@EuroELSO https://t.co/iPXh8iewk7 📃@E…
@sweidanmd @leticiakawano @f_g_zampieri @azevedo_lcp @PauloNassar1 @israelmaia16 @virenkaul @GallodeMoraesMD @FlaviaSepsis @laxswamy Curious what data you’re referring to re 28d mortality. The original ? is complex, but largest COVID ECMO study to date (h…
~60% de chance de sobreviver depois de ir pra ECMO. Em 24h da pra saber se o paciente está respondendo e deve continuar no hospital, ou é melhor desligar o aparelho. #PauloGustavo @PauloGustavo31 https://t.co/LT3tT69H9W
RT @dokter_onkologi: #ECMO (Extracorporeal Membrane Oxygenation). Last-Resort Life Support Option Helped Majority of Critically Ill #COVID1…
RT @dokter_onkologi: #ECMO (Extracorporeal Membrane Oxygenation). Last-Resort Life Support Option Helped Majority of Critically Ill #COVID1…
#ECMO (Extracorporeal Membrane Oxygenation). Last-Resort Life Support Option Helped Majority of Critically Ill #COVID19 Patients Survive, Global Study Shows https://t.co/JoLxibEYEt https://t.co/KBhDaetAk9
RT @AnestesiaH12O: @Ramifentanilo En este estudio de cohortes de The Lancet el intervalo de días para ECMO estaba entre 2 y 6.5 (mediana de…
RT @AnestesiaH12O: @Ramifentanilo En este estudio de cohortes de The Lancet el intervalo de días para ECMO estaba entre 2 y 6.5 (mediana de…
RT @AnestesiaH12O: @Ramifentanilo En este estudio de cohortes de The Lancet el intervalo de días para ECMO estaba entre 2 y 6.5 (mediana de…
@Ramifentanilo En este estudio de cohortes de The Lancet el intervalo de días para ECMO estaba entre 2 y 6.5 (mediana de 4) con una FiO2 de 100% entre 0.9 y 1.1 días y PAFI < 95 en cualquier caso. https://t.co/IHMsEXX6tN
@NidaQadirMD @ELSOOrg @SCCM @ATSCritCare @accpchest I'm sure you saw this already, but it was 70% in the Lancet study! https://t.co/KlAClfeGDK
@maculu @nickmmark Many have! In this study of over 1000 patients on ECMO for COVID, by the end of the study, 30% were home, 37% sadly died, and the rest were somewhere in between. https://t.co/KlAClfeGDK
RT @ELSOOrg: PS Full results of analysis of the ELSO Registry data to characterize epidemiology, hospital course, risk factors for mortalit…
RT @ELSOOrg: PS Full results of analysis of the ELSO Registry data to characterize epidemiology, hospital course, risk factors for mortalit…
RT @ELSOOrg: PS Full results of analysis of the ELSO Registry data to characterize epidemiology, hospital course, risk factors for mortalit…
I never thought id hear a whole section about #ECMO on @BBCNews, something i worked on whilst at @CARIMMaastricht but more for #cardiogenicshock not #COVID19! For those interested, here are a couple of links https://t.co/AwYKXs9eWH https://t.co/Bcl9d…
PS Full results of analysis of the ELSO Registry data to characterize epidemiology, hospital course, risk factors for mortality, outcomes of #ECLS in pts with lab confirmed #SARSCoV2 at https://t.co/UFHjDzLKRN All open access #COVIDFOAM #FOAMcc #COVID19…
RT @AvishaySpitzer: @PicturesZohar @RackMada יש בערך 40% תמותה. https://t.co/13OUFEEVqB
@PicturesZohar @RackMada יש בערך 40% תמותה. https://t.co/13OUFEEVqB
@Conralexx @Melhart1151 @FlorianSchwab Hier die Originalstudie mit allen Details https://t.co/QJfBruprnE
Contribuição importantíssima de nossa equipe de ECMO do Hospital de Clínicas de Porto Alegre no LANCET. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https…
@MSharifpourMD @HuzaifahSalat @Diana_Kelm @ELSOOrg @ECMOprincess @AvrahamCooperMD @Thind888 @laxswamy @sarahanifmirza @JonahRubinMD @efan75 Also - here's the link to the Lancet paper https://t.co/jCPBB4d50h
RT @SRAnesthesiaICU: Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is…
RT @SRAnesthesiaICU: Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is…
RT @SRAnesthesiaICU: Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is…
RT @SRAnesthesiaICU: Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is…
Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is only 40% around the world!! Thanks to this large #lancet study to document it in over 1000 patients 3/7 @BellomoRinaldo @alebelletti1…
RT @drhalat: Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Orga…
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry - The Lancet https://t.co/eNVKNluPkt
@screamingmd Largest study to date 1000+ patients courtesy of @ELSOOrg https://t.co/WOUq6mKgIM 61% survival to hospital discharge
@screamingmd Lancet: https://t.co/fFMPp1l1AU 1035 patients analyzed (90 days) - 37% mortality - 30% discharged to home or rehabilitation -10% to LTC; 17% another hospital - 6% still hospitalized EOLIA (2018): 35% mortality Definitely not futile in t…
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https://t.co/RnuKWRePtk
What outcomes can be expected in COVID-19 patients treated with ECMO? https://t.co/gTlpzqRZuK Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/ajerK16v2s
RT @LuisZuritaG: Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support…
Una opción en centros especializados. Muy cerca nuestro. Bucaramanga. Pero por favor que vaya quien lo necesita.
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https://t.co/Oj7kNBygA8
Excited to tune into Medicine Grand Rounds today and learn more about ECMO and Lung Transplantation for COVID-19 patients! Check out these articles published in @TheLancet on ECMO and Lung Transplantation for COVID patients. https://t.co/CYOOMKHm42 htt…
RT @McneillGregor: Thanks again to @DrJohnLivesey for presenting the recent ELSO registry paper at today’s SES CC Journal Club and thanks…
RT @McneillGregor: Thanks again to @DrJohnLivesey for presenting the recent ELSO registry paper at today’s SES CC Journal Club and thanks…
Thanks again to @DrJohnLivesey for presenting the recent ELSO registry paper at today’s SES CC Journal Club and thanks also to Dr Ian Scott from our National VV Ecmo Centre in @AberdeenICUEdu for joining us to discuss the paper #ecmo #ecls https://t.c…